Gwenaelle Pemberton

Gwenaelle Pemberton

Regulatory Advisor

Gwenaelle is a Regulatory Advisor to Syncona Investment Management Ltd.

Gwenaelle is a senior regulatory leader with over 30 years’ experience in global regulatory strategy in biopharma. Most recently, Gwenaelle was Vice President International Regulatory Affairs at Gilead, leading the International Regulatory Group which was responsible for regulatory activities worldwide, excluding the US. Gwenaelle has also worked for Pfizer, Pharmacia and AstraZeneca.

In her role at Syncona Gwenaelle provides strategic regulatory advice, updates on key regulatory developments, and helps the investment team to fully integrate regulatory considerations into investment decisions.

Gwenaelle holds a masters in Pharmaceutical Medicines from Hibernia College and a Master in Microbiology from l’Universite de Bretagne Occidentale.

Syncona portfolio companies

Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Markus John

Markus John

Chief Medical Officer and Head of R&D
Edward Hodgkin

Edward Hodgkin

Senior Partner
Elisa Petris

Elisa Petris

Lead Partner
Magdalena Jonikas

Magdalena Jonikas

Lead Partner
Alex Hamilton

Alex Hamilton

Investment Partner
Michael Kyriakides

Michael Kyriakides

Investment Partner
Gonzalo Garcia

Gonzalo Garcia

Investment Partner
Alice Renard

Alice Renard

Investment Partner
Raghd Rostom

Raghd Rostom

Associate Partner
Nathaniel Dahan

Nathaniel Dahan

Associate Partner
Lisa Bright

Lisa Bright

Commercial Advisor
Ben Woolven

Ben Woolven

Business Strategy and Operations Partner